Advent Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 03-12-2024
- Paid Up Capital ₹ 0.10 M
as on 03-12-2024
- Company Age 18 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.00 M
as on 03-12-2024
- Satisfied Charges ₹ 0.50 M
as on 03-12-2024
- Revenue -17.77%
(FY 2020)
- Profit -261.13%
(FY 2020)
- Ebitda -205.65%
(FY 2020)
- Net Worth -15.00%
(FY 2020)
- Total Assets -16.72%
(FY 2020)
About Advent Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.00 M. The company has closed loans amounting to ₹0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Praveen Kokate, Ganesh Dike, and Kishore Dhokne serve as directors at the Company.
- CIN/LLPIN
U85191MH2006PTC160553
- Company No.
160553
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Mar 2006
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nashik, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Advent Lifesciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Praveen Kokate  | Whole-Time Director | 17-Mar-2006 | Current |
| Ganesh Dike | Whole-Time Director | 17-Mar-2006 | Current |
| Kishore Dhokne | Whole-Time Director | 19-Jun-2006 | Current |
Financial Performance of Advent Lifesciences.
Advent Lifesciences Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 17.77% decrease. The company also saw a substantial fall in profitability, with a 261.13% decrease in profit. The company's net worth observed a substantial decline by a decrease of 15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Advent Lifesciences?
In 2020, Advent Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of Maharashtra Creation Date: 05 Jun 2007 | ₹2.00 M | Open |
Bank Of India Creation Date: 05 Oct 2010 | ₹0.50 M | Satisfied |
How Many Employees Work at Advent Lifesciences?
Advent Lifesciences has a workforce of 11 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Advent Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Advent Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
